
News|Articles|May 1, 2011
Formulary Digital Edition May 2011
A review of systemic lupus erythematosus and current treatment options; Bazedoxifene: An investigational selective estrogen receptor modulator for the treatment and prevention of osteoporosis in postmenopausal women; Agents in late-stage development for the treatment of major depressive disorder and generalized anxiety disorder
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Zepbound linked to lower healthcare costs in older adults with obesity
2
FDA approves Gilead’s Bixlenvo, smallest single-tablet option for virologically suppressed HIV patients
3
FDA approves brepocitinib for rare skin disease
4
Employer health care costs projected to rise 9.5% in 2027, report finds
5













